King International Investment Limited, an investment holding company, provides genetic testing and health data analysis services in the People’s Republic of China and Hong Kong. The company operates through two segments, Healthcare Products and Services Business, and Money Lending Business. The company also engages in money lending activities. In addition, it provides corporate administrative and healthcare services.
